DJIA 18,285.74 0.34 0.00%
NASDAQ 5,090.79 19.05 0.38%
S&P 500 2,130.82 4.97 0.23%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

74.27 0.91 (1.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LLY $74.27 1.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.34
Previous Close $73.36
Daily Range $73.18 - $74.35
52-Week Range $58.50 - $77.46
Market Cap $82.4B
P/E Ratio 35.79
Dividend (Yield) $2.00 (2.7%)
Ex-Dividend Date
Dividend Pay Date
05/14/15
06/10/15
Volume 3,288,096
Average Daily Volume 3,884,216
Current FY EPS $3.15

Sector

Healthcare

Industry

Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website: http://www.lilly.com/

News & Commentary Rss Feed

What Is the S&P 500 Index?

The S&P 500 Index and its component stocks.

Insider Trading Alert - MSFT, PMT And LLY Traded By Insiders

Notable ETF Inflow Detected - DGRW, MCD, BMY, LLY

4 Reasons Why MannKind Could Succeed Where Pfizer Failed

9 years ago Pfizer tried to launch an inhaled insulin called Exubera to the market and it failed. Here are 4 reasons why Afrezza could succeed where Pfizer came up short.

Week In Review: BeiGene Raises $97 Million For Cancer Drugs

Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog

Dendrimers Coming Of Age: Starpharma's Star Is Rising

Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2015

Eli Lilly & BioNTech Collaborate for Cancer Immunotherapies - Analyst Blog

5 Largest Markets for Pharmaceuticals

The pharmaceutical market is headed for $1.3 trillion by 2016. Here's how globalization is radically changing the game for Big Pharma and Big Biotech players.

See More LLY News...

LLY's Top Competitors

LLY $74.27 (1.24%)
Current stock: LLY
JNJ $102.42 (-0.42%)
Current stock: JNJ
NVS $104.79 (1.25%)
Current stock: NVS
RHHBY $37.18 (0.22%)
Current stock: RHHBY